EGFP-alphasynuclein-A53T Citations (28)
Originally described in: Alpha-synuclein overexpression promotes aggregation of mutant huntingtin.Furlong RA, Narain Y, Rankin J, Wyttenbach A, Rubinsztein DC Biochem J. 2000 Mar 15;346 Pt 3:577-81. PubMed Journal
Articles Citing EGFP-alphasynuclein-A53T
| Articles |
|---|
| Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease. Baksi S, Tripathi AK, Singh N. Free Radic Biol Med. 2016 Jun 23;97:292-306. doi: 10.1016/j.freeradbiomed.2016.06.025. PubMed |
| alpha-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients. Dieriks BV, Park TI, Fourie C, Faull RL, Dragunow M, Curtis MA. Sci Rep. 2017 Feb 23;7:42984. doi: 10.1038/srep42984. PubMed |
| Accumulation of autophagosomes confers cytotoxicity. Button RW, Roberts SL, Willis TL, Hanemann CO, Luo S. J Biol Chem. 2017 Jul 3. pii: jbc.M117.782276. doi: 10.1074/jbc.M117.782276. PubMed |
| New compounds identified through in silico approaches reduce the alpha-synuclein expression by inhibiting prolyl oligopeptidase in vitro. Kumar R, Bavi R, Jo MG, Arulalapperumal V, Baek A, Rampogu S, Kim MO, Lee KW. Sci Rep. 2017 Sep 7;7(1):10827. doi: 10.1038/s41598-017-11302-0. PubMed |
| Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of alpha-Synuclein via the Nrf2/HO-1 Pathway. Jo MG, Ikram M, Jo MH, Yoo L, Chung KC, Nah SY, Hwang H, Rhim H, Kim MO. Mol Neurobiol. 2019 Jan;56(1):39-55. doi: 10.1007/s12035-018-1020-1. Epub 2018 Apr 19. PubMed |
| Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson's disease. Chen J, Ren Y, Gui C, Zhao M, Wu X, Mao K, Li W, Zou F. Cell Death Dis. 2018 Jun 13;9(6):700. doi: 10.1038/s41419-018-0722-7. PubMed |
| Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models. Shaltouki A, Hsieh CH, Kim MJ, Wang X. Acta Neuropathol. 2018 Oct;136(4):607-620. doi: 10.1007/s00401-018-1873-4. Epub 2018 Jun 9. PubMed |
| Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, Hong Y, Ford C, Luo Y, Qi X. Acta Neuropathol. 2019 Jun;137(6):939-960. doi: 10.1007/s00401-019-01993-2. Epub 2019 Mar 15. PubMed |
| Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T alpha-synuclein. Goulding SR, Sullivan AM, O'Keeffe GW, Collins LM. Parkinsonism Relat Disord. 2019 Apr 11. pii: S1353-8020(19)30203-2. doi: 10.1016/j.parkreldis.2019.04.008. PubMed |
| Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling. Mazzocchi M, Wyatt SL, Mercatelli D, Morari M, Morales-Prieto N, Collins LM, Sullivan AM, O'Keeffe GW. Front Cell Dev Biol. 2019 Sep 13;7:191. doi: 10.3389/fcell.2019.00191. eCollection 2019. PubMed |
Negative regulation of autophagy by UBA6-BIRC6-mediated ubiquitination of LC3.
Jia R, Bonifacino JS.
Elife. 2019 Nov 6;8. pii: 50034. doi: 10.7554/eLife.50034.
PubMed
Associated Plasmids |
| Unconventional secretion of alpha-Crystallin B requires the Autophagic pathway and is controlled by phosphorylation of its serine 59 residue. D'Agostino M, Scerra G, Cannata Serio M, Caporaso MG, Bonatti S, Renna M. Sci Rep. 2019 Nov 15;9(1):16892. doi: 10.1038/s41598-019-53226-x. PubMed |
| p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T alpha-synuclein model of Parkinson's disease. Gui C, Ren Y, Chen J, Wu X, Mao K, Li H, Yu H, Zou F, Li W. Toxicol Appl Pharmacol. 2020 Feb 1;388:114874. doi: 10.1016/j.taap.2019.114874. Epub 2019 Dec 24. PubMed |
| Alterations in alpha-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons. Furlong RM, O'Keeffe GW, O'Neill C, Sullivan AM. Neurosci Lett. 2020 Feb 16;720:134777. doi: 10.1016/j.neulet.2020.134777. Epub 2020 Jan 21. PubMed |
| Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes alpha-synuclein degradation via transcription factor EB-dependent autophagy in mutant alpha-synucleinA53T model of Parkinson's disease. Mao K, Chen J, Yu H, Li H, Ren Y, Wu X, Wen Y, Zou F, Li W. Aging Cell. 2020 Jun;19(6):e13163. doi: 10.1111/acel.13163. Epub 2020 May 31. PubMed |
The ubiquitin isopeptidase USP10 deubiquitinates LC3B to increase LC3B levels and autophagic activity.
Jia R, Bonifacino JS.
J Biol Chem. 2021 Jan-Jun;296:100405. doi: 10.1016/j.jbc.2021.100405. Epub 2021 Feb 10.
PubMed
Associated Plasmids |
| In situ architecture of neuronal alpha-Synuclein inclusions. Trinkaus VA, Riera-Tur I, Martinez-Sanchez A, Bauerlein FJB, Guo Q, Arzberger T, Baumeister W, Dudanova I, Hipp MS, Hartl FU, Fernandez-Busnadiego R. Nat Commun. 2021 Apr 14;12(1):2110. doi: 10.1038/s41467-021-22108-0. PubMed |
| The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model. Yuste-Checa P, Trinkaus VA, Riera-Tur I, Imamoglu R, Schaller TF, Wang H, Dudanova I, Hipp MS, Bracher A, Hartl FU. Nat Commun. 2021 Aug 11;12(1):4863. doi: 10.1038/s41467-021-25060-1. PubMed |
| Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Wang C, Lau CY, Ma F, Zheng C. Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). pii: 2106504118. doi: 10.1073/pnas.2106504118. PubMed |
| p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. Chen J, Mao K, Yu H, Wen Y, She H, Zhang H, Liu L, Li M, Li W, Zou F. J Neuroinflammation. 2021 Dec 20;18(1):295. doi: 10.1186/s12974-021-02349-y. PubMed |
| Polygala saponins inhibit NLRP3 inflammasome-mediated neuroinflammation via SHP-2-Mediated mitophagy. Qiu WQ, Ai W, Zhu FD, Zhang Y, Guo MS, Law BY, Wu JM, Wong VK, Tang Y, Yu L, Chen Q, Yu CL, Liu J, Qin DL, Zhou XG, Wu AG. Free Radic Biol Med. 2022 Feb 1;179:76-94. doi: 10.1016/j.freeradbiomed.2021.12.263. Epub 2021 Dec 20. PubMed |
| Sequestration of TDP-43(216-414) Aggregates by Cytoplasmic Expression of the proSAAS Chaperone. Peinado JR, Chaplot K, Jarvela TS, Barbieri EM, Shorter J, Lindberg I. ACS Chem Neurosci. 2022 Jun 1;13(11):1651-1665. doi: 10.1021/acschemneuro.2c00156. Epub 2022 May 12. PubMed |
| Reduction of phosphorylated alpha-synuclein through downregulation of casein kinase 2alpha alleviates dopaminergic-neuronal function. Potdar C, Kaushal A, Raj A, Mallick R, Datta I. Biochem Biophys Res Commun. 2022 Jul 30;615:43-48. doi: 10.1016/j.bbrc.2022.05.023. Epub 2022 May 11. PubMed |
| Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance. Wrobel L, Hill SM, Djajadikerta A, Fernandez-Estevez M, Karabiyik C, Ashkenazi A, Barratt VJ, Stamatakou E, Gunnarsson A, Rasmusson T, Miele EW, Beaton N, Bruderer R, Feng Y, Reiter L, Castaldi MP, Jarvis R, Tan K, Burli RW, Rubinsztein DC. Nat Commun. 2022 Jul 16;13(1):4146. doi: 10.1038/s41467-022-31905-0. PubMed |
| Retrograde Axonal Autophagy and Endocytic Pathways Are Parallel and Separate in Neurons. Kulkarni VV, Stempel MH, Anand A, Sidibe DK, Maday S. J Neurosci. 2022 Nov 9;42(45):8524-8541. doi: 10.1523/JNEUROSCI.1292-22.2022. Epub 2022 Sep 27. PubMed |
| O-Cyclic Phytosphingosine-1-Phosphate Protects against Motor Dysfunctions and Glial Cell Mediated Neuroinflammation in the Parkinson's Disease Mouse Models. Lee HJ, Choe K, Park JS, Khan A, Kim MW, Park TJ, Kim MO. Antioxidants (Basel). 2022 Oct 26;11(11):2107. doi: 10.3390/antiox11112107. PubMed |
| The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons. Russo T, Kolisnyk B, Bs A, Kim TW, Martin J, Plessis-Belair J, Ni J, Pearson JA, Park EJ, Sher RB, Studer L, Riessland M. bioRxiv. 2023 Jul 21:2023.07.19.549710. doi: 10.1101/2023.07.19.549710. Preprint. PubMed |
| Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways. Park JS, Choe K, Lee HJ, Park TJ, Kim MO. J Biomed Sci. 2023 Aug 11;30(1):66. doi: 10.1186/s12929-023-00961-z. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.